Pentagon reinstates testosterone testing policy for service members over 30

The Department of Defense announced a new health‑screening directive that will require all active‑duty service members aged 31 and older to undergo annual testosterone level testing. The policy, issued by the Army Medical Command, is presented as a measure to maintain combat readiness by identifying hormonal deficiencies that could impair physical performance, mood stability, and recovery. Under the program, personnel will have blood drawn during routine medical examinations, and results will be entered into the existing medical record system for evaluation by military health providers.

Medical ethicists and endocrinology specialists have expressed concerns about the mandate, noting that routine testosterone screening in asymptomatic individuals can lead to overdiagnosis, unnecessary treatment, and potential side effects such as cardiovascular strain, mood disturbances, and fertility issues. Critics also point to the lack of clear evidence linking baseline testosterone levels with measurable improvements in operational capability. The Department of Defense has responded that participation will be voluntary in terms of follow‑up care, and that data will be used solely to inform health‑maintenance programs while safeguarding privacy. The policy is set to take effect at the start of the next fiscal year, with implementation monitored across all service branches.